| In millions, except per share items | Jun-29-14 | Jun-30-13 | Jul-01-12 | Jul-03-11 | Jun-27-10 | Jun-28-09 | Jun-29-08 | Jul-01-07 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Total revenues | 447.3 | 478.6 | 501.8 | 452.5 | 399.2 | 378.2 | 488.3 | 470.2 |
| Revenue growth | -6.5% | -4.6% | 10.9% | 13.4% | 5.5% | -22.5% | 3.9% | 16.7% |
| Cost of goods sold [+] | 365.2 | 394.6 | 454.6 | 400.8 | 152.5 | 146.5 | 187.1 | 195.6 |
| Cost of product sales | 186.3 | 199.8 | 245.9 | 200.4 | 133.6 | 127.5 | | |
| Amortization of intangibles | 24.9 | 21.8 | 24.0 | 33.1 | | | | |
| Gross profit | 82.1 | 84.0 | 47.2 | 51.7 | 246.7 | 231.8 | 301.2 | 274.6 |
| Gross margin | 18.4% | 17.6% | 9.4% | 11.4% | 61.8% | 61.3% | 61.7% | 58.4% |
| Selling, general and administrative [+] | 118.9 | 105.1 | 95.6 | 114.8 | 107.0 | 95.3 | 96.5 | 79.3 |
| Sales and marketing | 77.8 | 66.2 | 60.0 | 58.6 | 56.6 | 53.5 | 57.9 | 47.9 |
| General and administrative | 41.1 | 38.9 | 35.7 | 56.1 | 50.5 | 41.9 | 38.5 | 31.4 |
| Research and development | 155.9 | 168.4 | 163.6 | 170.8 | 126.9 | 129.8 | 129.2 | 117.8 |
| Other operating expenses | -172.5 | -188.9 | -202.1 | -191.1 | 6.8 | -580.7 | 9.3 | 14.1 |
| EBITDA [+] | 30.2 | 45.2 | 38.7 | 20.9 | 52.7 | 633.9 | 150.0 | 156.8 |
| EBITDA growth | -33.3% | 16.8% | 85.6% | -60.4% | -91.7% | 322.6% | -4.4% | 7.4% |
| EBITDA margin | 6.7% | 9.5% | 7.7% | 4.6% | 13.2% | 167.6% | 30.7% | 33.4% |
| Depreciation | 19.0 | 18.2 | 18.1 | 21.2 | 20.9 | 22.3 | 51.4 | 55.5 |
| EBITA | 11.1 | 27.0 | 20.7 | -0.4 | 31.7 | 611.5 | 98.6 | 101.3 |
| EBITA margin | 2.5% | 5.6% | 4.1% | -0.1% | 8.0% | 161.7% | 20.2% | 21.5% |
| Amortization of intangibles | 31.3 | 27.7 | 30.6 | 42.5 | 25.7 | 24.3 | 32.3 | 37.9 |
| EBIT [+] | -20.2 | -0.7 | -9.9 | -42.8 | 6.0 | 587.3 | 66.3 | 63.4 |
| EBIT growth | 2743.3% | -92.9% | -76.8% | -808.6% | -99.0% | 786.4% | 4.5% | -19.1% |
| EBIT margin | -4.5% | -0.1% | -2.0% | -9.5% | 1.5% | 155.3% | 13.6% | 13.5% |
| Non-recurring items [+] | | | | 6.0 | | 586.0 | | 19.2 |
| Asset impairment | | | | 6.0 | | | | |
| In-process research & development | | | | | | | | 19.2 |
| Interest income, net [+] | -5.8 | 0.0 | 0.1 | -0.3 | 0.3 | 4.3 | 11.6 | 18.8 |
| Interest expense | 5.9 | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 1.2 |
| Interest income | 0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 4.4 | 11.7 | 20.0 |
| Other income (expense), net [+] | -0.2 | -4.9 | 0.3 | -9.8 | 0.0 | 0.0 | 0.0 | -3.9 |
| Impairment of investments | | | | -9.2 | | | | |
| Other | -0.2 | -4.9 | 0.4 | -0.6 | 0.0 | 0.0 | | 3.9 |
| Pre-tax income | -26.2 | -5.6 | -9.5 | -58.8 | 6.3 | 5.6 | 77.9 | 59.1 |
| Income taxes | 3.3 | -0.4 | 1.6 | 24.8 | -17.3 | -1.9 | 85.0 | 29.6 |
| Tax rate | | 6.6% | | | | | 109.1% | 50.2% |
| Net income | -29.5 | -5.2 | -11.1 | -83.6 | 23.6 | 7.5 | -7.1 | 29.4 |
| Net margin | -6.6% | -1.1% | -2.2% | -18.5% | 5.9% | 2.0% | -1.4% | 6.3% |
| |
| Basic EPS [+] | ($0.35) | ($0.06) | ($0.13) | ($0.97) | $0.29 | $0.09 | ($0.09) | $0.35 |
| Growth | 509.3% | -54.9% | -86.8% | -429.5% | 215.7% | -208.7% | -124.7% | -27.8% |
| Diluted EPS [+] | ($0.35) | ($0.06) | ($0.13) | ($0.97) | $0.29 | $0.09 | ($0.09) | $0.33 |
| Growth | 509.3% | -54.9% | -86.8% | -434.4% | 212.4% | -208.3% | -126.0% | -25.5% |
| |
| Shares outstanding (basic) [+] | 83.9 | 90.3 | 86.6 | 86.0 | 80.1 | 80.8 | 82.3 | 84.5 |
| Growth | -7.0% | 4.3% | 0.6% | 7.4% | -0.8% | -1.9% | -2.6% | 0.7% |
| Shares outstanding (diluted) [+] | 83.9 | 90.3 | 86.6 | 86.0 | 81.3 | 81.1 | 82.3 | 89.1 |
| Growth | -7.0% | 4.3% | 0.6% | 5.9% | 0.2% | -1.5% | -7.6% | -2.4% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |